Antimicrobial stewardship is an organizational priority mandated by standards released from The Joint Commission and CMS to address growing concerns over antimicrobial resistance. With reimbursement and patient safety at stake, Sentri7 helps hospitals and health systems improve appropriate use of antibiotics, while arming clinicians with information to minimize drug costs, prevent harm, or avoid a potential medical situation.
Sentri7 helps hospitals quickly improve drug utilization and identify cost-saving opportunities to deliver tangible impacts on quality and expense. Care teams depend on Sentri7’s high-impact alerts to guide proper therapy, flag antimicrobial misuse, and identify opportunities to contain drug costs by proactively flagging drug substitutes.
Sentri7 gives us the ability to manage our larger target clinical initiatives like AMS, as well as tailor our own rules as necessary, which gives us a lot of flexibility and control. We’ve seen a reduction of about $2 million in AMS spend alone since the inception of the program, as well as better patient outcomes.
~Matt Baldwin, Pharm.D, Executive Director of Pharmacy for Aultman Hospital, part of a 1032-bed not-for-profit hospital system located in Ohio.
Antimicrobial stewardship is only as successful as the program that supports a hospital’s efforts. Wolters Kluwer clinical experts help care teams develop robust programs based on a hospital’s current efforts and the actions required to align with the CDC core elements of an effective antimicrobial stewardship program. Learn more about Wolters Kluwer clinical services.
Access hundreds of out-of-the-box rules aligned with core AMS guidelines and the latest evidence-based practices.
Analytics & Reporting
Know the relevant goals and timelines for the National Action Strategy for Combating Antibiotic-Resistant Bacteria
Understand regulations, guidelines, penalties and preparation to build your antimicrobial stewardship program
Written for clinicians